Amanda Pedersen, Senior Editor at MD+DI, reflects on the medical device and diagnostics industry in 2023, including challenges, layoffs, and positive surprises. They also discuss the conclusion of the Theranos saga, Phillips' ongoing recalls, the divestment of grail by Illumina, and the excitement for the future of PFA in Medtech.
The year 2023 brought challenges and positive developments for the medical device industry, including layoffs, shutdowns, regulatory controversies, and the closure of the Theranos saga with Elizabeth Holmes going to prison.
Two emerging areas to watch in MedTech are post-field ablation treatments for atrial fibrillation and renal denervation, which are expected to fuel innovation, provide more options for physicians, and show potential for growth and a new treatment paradigm.
Deep dives
The Medical Device Industry in 2023
2023 was the first post-COVID year for the medical device and diagnostics industry, marking a return to normalcy. The year brought both challenges and surprises, with companies facing layoffs, shutdowns, and regulatory controversies. However, there were also positive developments, such as the closure of the Theranos saga with Elizabeth Holmes going to prison. The industry faced reputation challenges due to recalls by companies like Philips, highlighting the need for stronger accountability in the industry. Despite the setbacks, there is optimism for the future of MedTech in 2024.
Post-field Ablation and Renal Denervation
Two emerging areas of MedTech to watch are post-field ablation and renal denervation. Post-field ablation treatments for atrial fibrillation are generating excitement with multiple companies vying for FDA approval. The competition in this space will fuel innovation and provide physicians with more options to treat patients. Similarly, renal denervation is seeing a plot twist with Medtronic gaining FDA approval after a series of setbacks. This turnaround in the hypertension treatment market shows the potential for growth and a new treatment paradigm.
Looking Ahead: Trends in MedTech for 2024
As the medical device industry emerges from the pandemic, 2024 is expected to be a defining year for MedTech. Alternative funding routes, like venture capital arms and startup contests, will become more common as traditional funding sources become more challenging. Areas like diabetes tech and outpatient care will continue to see growth. Additionally, companies are taking steps to consolidate and streamline their supply chains, improving efficiency and strengthening supplier partnerships. Overall, 2024 holds promise for innovation, adaptation, and a new standard in the MedTech industry.
MD+DI's Senior Editor, Amanda Pedersen joins us for this episode of Let's Talk Medtech to look at what 2023 was for the medical device and diagnostics industry. The veteran journalist also dives into what the future might hold in 2024 for the industry.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode